# IPCALAB share price, delivery % and history — IPCA Laboratories Limited

> Delivery percentage for IPCA Laboratories Limited (IPCALAB) against its own history, with 7,833 sessions of split-adjusted NSE data from 1995 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/IPCALAB

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 1,927 INR (-0.57% on the day), 2026-09-30
- Delivery: 61.24% of volume taken to demat (20-day average 55.31%)
- Volume: 3.12L shares, turnover ₹60.2Cr
- Relative volume: 1.32× of its own 20-day average

## Technicals

- RSI(14): 47.85
- ATR(14): 57.26
- SMA 50: 1,879.96, SMA 200: 1,626.69
- 52-week range: 1,251.6 – 2,038 (-5.45% from the high)

## Performance

- 1 week -1.81%, 1 month -2.43%, 3 months 12.07%
- 6 months 21.5%, 1 year 38.12%

## Delivery percentage

- Latest: 61.24% (2026-09-30)
- 20-day average: 55.31%
- 1-year average: 49.33%
- Percentile against its own history: 83th
- Range: 11.82% – 93.86% across 1,728 sessions with a reading

Over the last 20 sessions IPCALAB settled 55.3% of its traded quantity, which is above average for an NSE equity. Its one-year average is 49.3%, so recent sessions are running 6.0 points higher than usual. The latest session ranks higher than 83% of the 1,728 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 48,888.8 crore
- P/E (TTM): 35.55 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 54.2 INR, split-adjusted to match the price series
- Revenue growth: 20.76% YoY, 16.73% QoQ
- Profit growth: 82.18% YoY, 38.34% QoQ

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 2,354.9 | 2,036.3 | 344.8 | 245.8 | 9.05 | 10.44% |
| 2024-12-31 | 2,245.4 | 1,897.6 | 367.9 | 276.4 | 9.78 | 12.31% |
| 2025-03-31 | 2,246.7 | 1,939.5 | 128 | 64 | 2.67 | 2.85% |
| 2025-06-30 | 2,308.9 | 2,011 | 330.5 | 232.9 | 9.19 | 10.09% |
| 2025-09-30 | 2,556.5 | 2,134.5 | 391.6 | 280.5 | 11.14 | 10.97% |
| 2025-12-31 | 2,392.5 | 1,984.4 | 446 | 363.7 | 12.86 | 15.2% |
| 2026-03-31 | 2,388.5 | 2,032 | 404.5 | 306.7 | 11.79 | 12.84% |
| 2026-06-30 | 2,788.1 | 2,241.3 | 572.1 | 424.3 | 15.84 | 15.22% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 44.72%
- Public: 55.28%
- FII: 10.73%, DII: 37.37%
- Promoter shares pledged: 0%

## Recent filings

- 2026-08-13: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_186552_13082026170720_iXBRL_WEB.html
- 2026-08-07: dividend
- 2026-07-17: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1694779_17072026104110_WEB.xml
- 2026-05-29: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_163643_29052026171037_iXBRL_WEB.html
- 2026-04-08: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1647122_08042026120805_WEB.xml
- 2026-02-13: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_142908_13022026162621_iXBRL_WEB.html
- 2026-01-14: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1600704_14012026034809_WEB.xml
- 2025-11-13: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_127133_13112025154311_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 120 events are indexed for this instrument.

## About the instrument

- Listed: 1995-01-02 — latest session 2026-09-30 (7,833 sessions)
- ISIN: INE571A01038
- Series: EQ
- Liquidity rank: #500 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/IPCALAB.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.